Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
Conditions:   Buerger Disease;   Raynaud Syndrome Intervention:   Drug: BOTOX INJECTION Sponsor:   University Hospital, Toulouse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2023 Category: Research Source Type: clinical trials

Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger's Disease
Conditions:   Non-healing Wound;   Thromboangiitis Obliterans Intervention:   Drug: Selexipag Sponsor:   Actelion Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2021 Category: Research Source Type: clinical trials